Megmadruff 2% Shampoo is an anti-fungal medicine used for the treatment of dandruff. It kills and inhibits the growth of microorganisms that cause dandruff. It also hydrates the scalp and provides relief from itchiness and flakiness associated with dandruff.
Megmadruff 2% Shampoo is for external use only. Use it in the exact dose and duration advised by your doctor. Read the instructions thoroughly before using the medicine. Do not use it more than the recommended dose. Continue using it for as long as the doctor has prescribed. Avoid direct contact with your eyes. In the case of accidental contact, rinse it off thoroughly with cold water.
Common side effects of this medicine include burning, itching, irritation, and redness at the application site. Occasionally, it can cause thinning of your hair. These are not usually serious, but if they persist or get worse, let your doctor know. Your doctor may be able to suggest ways to reduce or treat them.
Before using Megmadruff 2% Shampoo, inform your doctor if you have a known history of allergic reaction to ketoconazole or any of the ingredients in this product. Let your doctor also know if you have recently used another medicine that contains a steroid or had an allergic reaction to another antifungal medicine. To make sure it is safe, pregnant and breastfeeding women should consult their doctor before using this medicine.
Dandruff is a scalp condition that causes flaking, itching, and irritation due to excess skin cell shedding, often linked to yeast overgrowth on the scalp. Megmadruff 2% Shampoo helps reduce the growth of this yeast, relieving itching and flaking, and restoring a healthier scalp.
Side effects of Megmadruff Shampoo
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Megmadruff
No common side effects seen
How to use Megmadruff Shampoo
Use it as advised by your doctor or check the label for directions before use.
How Megmadruff Shampoo works
Megmadruff 2% Shampoo is an antifungal medication. It kills and stops the growth of the fungi by destroying its cell membrane, thereby treating your skin infection.
Safety advice
Alcohol
No interaction found/established
Pregnancy
No interaction found/established
Breast feeding
No interaction found/established
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
What if you forget to take Megmadruff Shampoo?
If you miss a dose of Megmadruff 2% Shampoo, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Dandruff and skin allergy due to dandruff, rashes on skin due to dandruff
Dr. Souvik Sardar
Dermatology
Due SCALPE LOTION - thrice weekly on alternate day for 4wks. . Kip it for 5mins in wet scalp and wash offPost pictures of the allegyPlz post a picture wch will help me to diagnose and treat use proper light else plz visit a dermatologist for a face to face consultation and examination
Facing too much dandruff problem and hair fall. Regularly using anti dandruff shampoo but still next day dandruff comes there. It's a kind of wet dandruff.
Megmadruff 2% Shampoo is used to treat and prevent fungal scalp and skin conditions caused by Malassezia yeast. It is commonly used for dandruff, seborrhoeic dermatitis, and tinea (pityriasis) versicolor, where it helps reduce flaking, itching, and scaling.
How should Megmadruff 2% Shampoo be used?
Megmadruff 2% Shampoo is meant for external use only. It should be applied to the affected area, left on for 3–5 minutes, and then rinsed off. The frequency of use depends on the condition being treated, such as twice weekly for dandruff or once daily for tinea versicolor.
How long does it take to see results?
Improvement in dandruff is usually seen within 2–4 weeks of regular use. Use it in the dose and duration prescribed by your doctor.
Can Megmadruff 2% Shampoo be used in children?
The safety and effectiveness of Megmadruff 2% Shampoo have not been established in children under 12 years of age. It should not be used in children unless advised otherwise by a doctor.
Are there any side effects of Megmadruff 2% Shampoo?
Most people tolerate Megmadruff 2% Shampoo well. Some may experience mild scalp or skin reactions such as irritation, dryness, itching, or changes in hair texture. If severe irritation or allergic reactions occur, stop the use and seek medical advice.
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
References
Schimmer BP, Funder JW. ACTH, Adrenal Steroids, and Pharmacology of the Adrenal Cortex. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1233.
Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1576.
Chrousos GP. Adrenocorticosteroids & Adrenocortical Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 693.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 758-59.